Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MLND

Millendo Therapeutics (MLND) Stock Price, News & Analysis

Millendo Therapeutics logo

About Millendo Therapeutics Stock (NASDAQ:MLND)

Advanced Chart

Key Stats

Today's Range
$7.14
$7.74
50-Day Range
$3.06
$5.84
52-Week Range
$0.92
$16.95
Volume
51,264 shs
Average Volume
1.52 million shs
Market Capitalization
$137.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MLND Stock News Headlines

If you saw this, you'd be scared too
Markets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ years of navigating crashes and crises, he says traditional strategies could soon become wealth destroyers. A time-sensitive briefing reveals what to do now.
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Expert Ratings for Decibel Therapeutics
See More Headlines

MLND Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Millendo Therapeutics investors own include Elbit Systems (ESLT), UnitedHealth Group (UNH), AbbVie (ABBV), American Water Works (AWK), Bright Health Group (BHG), Black Hills (BKH) and Blackrock Municipal 2030 Target Term Trust (BTT).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MLND
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$36.41 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-91.03%
Return on Assets
-72.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.39
Quick Ratio
6.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.78 per share
Price / Book
4.06

Miscellaneous

Outstanding Shares
19,043,000
Free Float
N/A
Market Cap
$137.68 million
Optionable
Not Optionable
Beta
0.48
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MLND) was last updated on 8/1/2025 by MarketBeat.com Staff
From Our Partners